spacer
home > ebr > spring 2019 > trusting in biobanking
PUBLICATIONS
European Biopharmaceutical Review

Trusting in Biobanking

Biobanking is used to create large scale repositories of human biological material, such as blood, urine, tissue, and DNA, to further medical research. Research institutes, hospitals, and biopharmaceutical and biotechnology companies rely on biobanks to advance research of new therapies and for the identification of disease biomarkers from large patient cohorts. Biobanking supports a number of modern research techniques, including genomics and personalised medicine, by allowing researchers to better understand who is most at risk of certain diseases and what treatments they may best respond to. A number of biobanks exist worldwide, each containing hundreds of thousands of samples to contribute to the growing pool of knowledge and safeguarding public health in future generations.

Nuclear Magnetic Resonance and Biobanking

Sample collection, preparation, analysis, storage, transport, and data management must all be highly standardised in biobanking. Samples that are stored over decades can change, and researchers can never guarantee that a sample will remain unchanged over time. The high reproducibility of nuclear magnetic resonance (NMR) spectroscopy makes it an important analytical tool for biobank samples. It can characterise stored samples and determine whether any changes could lead to artefacts.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Matthias Nauck is a Professor at the Institute of Clinical Chemistry at University Medicine Greifswald, Germany. His role is split between a focus on patient care and a range of scientific research projects. Matthias has played an integral role in introducing NMR to the lab at Greifswald for epidemiological research and biobanking studies.
spacer
Matthias Nauck
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo maintains its dual-terminal operations seamlessly

Completing the gradual transition process to Istanbul Airport, one of the largest airports of the world, the global air cargo brand Turkish Cargo maintains its dual-terminal operations with full capacity on 7/24 basis without any sales restriction.
More info >>

White Papers

Contemporary Issues in Comparator Trial Supply

Clinigen CTS

As trial design and execution becomes ever-more complex, initiatives to adapt, increase efficiency and control costs without compromising quality become paramount. Here, Clinigen CTS covers the broad issues and summarises the responses our industry is making in this increasingly demanding landscape.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: itís where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on todayís hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement